Targeting Aggressive Hepatocellular Carcinoma: A Combined Anti-Angiogenesis and Immunotherapy Approach (IMAGE)
Caption
Combining angiogenesis inhibition with immune checkpoint blockade is a promising therapeutic strategy for treating aggressive HCC subtype.
Credit
Science Tokyo
Usage Restrictions
None
License
Original content